Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus. (Q40479713)

20 September 2017

Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus. (English)

1 reference

20 September 2017

1 reference

Newcastle disease virus

object named as

Newcastle disease virus

1 reference

4

Ben Peeters

1 reference

20 September 2017

Huijie Bian

1

1 reference

20 September 2017

Philippe Fournier

series ordinal

2

1 reference

20 September 2017

Rob Moormann

series ordinal

3

1 reference

20 September 2017

Volker Schirrmacher

series ordinal

5

1 reference

20 September 2017

1 March 2005

1 reference

20 September 2017

1 reference

20 September 2017

12

1 reference

20 September 2017

3

1 reference

20 September 2017

295-303

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700774

20 September 2017

0 references

cites work

Application of autologous tumor cell vaccine and NDV vaccine in treatment of tumors of digestive tract

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

Recombinant Newcastle disease virus as a viral vector: effect of genomic location of foreign gene on gene expression and virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

Characterization of a recombinant Newcastle disease virus expressing the green fluorescent protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

Newcastle disease virus (NDV): brief history of its oncolytic strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

Recombinant Newcastle disease virus as a vaccine vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

Induction of interferon-alpha and tumor necrosis factor-related apoptosis-inducing ligand in human blood mononuclear cells by hemagglutinin-neuraminidase but not F protein of Newcastle disease virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

Targeting of adenovirus to human renal cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

Tropism-modified adenoviral and adeno-associated viral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

Altered interleukin-2 receptor alpha-chain is expressed in human T-cell leukaemia virus type-I-infected T-cell lines and human peripheral blood mononuclear cells of adult T-cell leukaemia patients through an alternative splicing mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

The IL-2/IL-15 receptor systems: targets for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

RNA viruses as virotherapy agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

Negative-strand RNA viruses: genetic engineering and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

An oncolytic measles virus engineered to enter cells through the CD20 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

Recovery of a virulent strain of newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

Generation of recombinant lentogenic Newcastle disease virus from cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

High-level expression of a foreign gene from the most 3'-proximal locus of a recombinant Newcastle disease virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

T-cell priming in bone marrow: the potential for long-lasting protective anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

inferred from DOI database lookup

7 January 2021

based on heuristic

Tissue tropism in the chicken embryo of non-virulent and virulent Newcastle diseases strains that express green fluorescence protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700774

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CGT.7700774

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference